Skip to main content

Published locations for FDA alert: Canagliflozin use may be associated with toe, foot amputations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA alert: Canagliflozin use may be associated with toe, foot amputations

User login

  • Reset your password
  • /content/fda-alert-canagliflozin-use-may-be-associated-toe-foot-amputations
  • /familypracticenews/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /ehospitalistnews/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /internalmedicinenews/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /acssurgerynews/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /clinicalendocrinologynews/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe
  • /diabeteshub/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /endocrinology/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /internalmedicine/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /familymedicine/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot
  • /surgery/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot-amputations
  • /type-2-diabetes-icymi/article/108964/diabetes/fda-alert-canagliflozin-use-may-be-associated-toe-foot